MEW-31225-95571 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-23
Health check-in — day 0, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · Headache, Joint pains

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains · Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activities

Adult check-in
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities

Adult check-in
2021-01-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Adult check-in
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities

Adult check-in
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-26
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-02-09
Survey response — day 28, dose 2
MedDRA: Arthralgia — Feeling: Good

Free text: Worsening shoulder pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-22
Call 1 — Left Voicemail
2021-03-22
Call 1 — Left Voicemail
2021-03-22
Call 1 — Left Voicemail
2021-03-22
Call 1 — Left Voicemail
2021-03-22
Call 1 — Left Voicemail
2021-09-08
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-09-08
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-09-20
Survey response — day 7, dose 4
MedDRA: Pre-eclampsia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Severe preeclampsia diagnosis 9/14, no symptoms prior

MedDRA releases: 2024-11 · check-in free text available
2022-09-20
Report sent to call center — day 7, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-09-21
Call 1 — Could Not Reach Participant
2022-09-21
Callback requested for
01:15PM ET
2022-09-26
Call 2 — Left Voicemail
2022-09-26
Call 2 — Left Voicemail
2022-09-26
Call 2 — Left Voicemail
2022-09-26
Call 2 — Left Voicemail
2022-09-26
Call 2 — Left Voicemail
2022-09-26
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-09-08	Pfizer-BioNTech	Flu
4	2022-09-08	Pfizer-BioNTech	Flu

Call center

6 call center cases

6 unsuccessful

See the call center timeline

Free text

Release 3 — day 28, dose 2

2021-02-09

Symptoms: Worsening shoulder pain

Release 12 — day 7, dose 4

2022-09-20

Systemic reaction (other): Severe preeclampsia diagnosis 9/14, no symptoms prior

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	✓	✓	✓
SRO	Pre-eclampsia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release